vs

Side-by-side financial comparison of NewGenIvf Group Ltd (NIVF) and Bio-Techne (TECH). Click either name above to swap in a different company.

NewGenIvf Group Ltd is a specialized assisted reproductive technology (ART) service provider. It offers a full range of fertility solutions including in vitro fertilization, preimplantation genetic testing and fertility preservation, primarily serving clients across Greater China and Southeast Asia, including both local and cross-border patients seeking reproductive care.

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NIVF
NIVF
TECH
TECH
Q4 25
$295.9M
Q2 25
$317.0M
Q1 25
$316.2M
Q4 24
$297.0M
Q3 24
$289.5M
Q2 24
$306.1M
Q1 24
$303.4M
Q4 23
$272.6M
Net Profit
NIVF
NIVF
TECH
TECH
Q4 25
$38.0M
Q2 25
$-17.7M
Q1 25
$22.6M
Q4 24
$34.9M
Q3 24
$33.6M
Q2 24
$40.6M
Q1 24
$49.1M
Q4 23
$27.5M
Gross Margin
NIVF
NIVF
TECH
TECH
Q4 25
64.6%
Q2 25
62.7%
Q1 25
67.9%
Q4 24
65.3%
Q3 24
63.2%
Q2 24
66.4%
Q1 24
67.4%
Q4 23
64.8%
Operating Margin
NIVF
NIVF
TECH
TECH
Q4 25
18.4%
Q2 25
-7.5%
Q1 25
12.2%
Q4 24
16.0%
Q3 24
13.8%
Q2 24
15.0%
Q1 24
22.1%
Q4 23
13.9%
Net Margin
NIVF
NIVF
TECH
TECH
Q4 25
12.8%
Q2 25
-5.6%
Q1 25
7.1%
Q4 24
11.7%
Q3 24
11.6%
Q2 24
13.3%
Q1 24
16.2%
Q4 23
10.1%
EPS (diluted)
NIVF
NIVF
TECH
TECH
Q4 25
$0.24
Q2 25
$-0.11
Q1 25
$0.14
Q4 24
$0.22
Q3 24
$0.21
Q2 24
$0.26
Q1 24
$0.31
Q4 23
$0.17

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons